FDA Orange Book · active-ingredient family
Pralidoxime chloride
Pralidoxime chloride is approved in 4 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:PRALIDOXIME CHLORIDE (AUTOINJECTOR) · NDA 018986
4
Brand (NDA)
0
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · injectable, solution, tablet
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| PRALIDOXIME CHLORIDE (AUTOINJECTOR)RLD | MERIDIAN MEDCL TECHN | NDA 018986 | — | Apr 26, 1983 | |
| PROTOPAM CHLORIDERLD | BAXTER HLTHCARE CORP | NDA 014134 | — | Approved Prior to Jan 1, 1982 | |
| PRALIDOXIME CHLORIDE | BAXTER HLTHCARE CORP | NDA 018799 | — | Dec 13, 1982 | |
| PROTOPAM CHLORIDE | WYETH AYERST | NDA 014122 | — | Approved Prior to Jan 1, 1982 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Pralidoxime chloride — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
